4//SEC Filing
ACADIA PHARMACEUTICALS INC 4
Accession 0001209191-05-031872
$ACADCIK 0001070494operating
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:37 PM ET
Size
7.8 KB
Accession
0001209191-05-031872
Insider Transaction Report
Form 4
van Osch Martien
Director
Transactions
- Award
Stock Option (Right to Buy)
2005-06-10+6,500→ 6,500 totalExercise: $8.85Exp: 2015-06-09→ Common Stock (6,500 underlying) - Award
Stock Option (Right to Buy)
2005-06-10+5,084→ 5,084 totalExercise: $8.85Exp: 2015-06-09→ Common Stock (5,084 underlying)
Footnotes (2)
- [F1]One-fourth of the shares subject to the Stock Option shall vest and become exercisable at the end of each 3 month period following the date of grant.
- [F2]The Reporting Person has elected to convert annual retainer fees of $15,000 into a stock option under the terms of the Issuer's Outside Director Compensation Program.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070494
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:37 PM ET
- Size
- 7.8 KB